Global Non-Invasive Glucose Monitoring Patent Landscape Report 2024

Global Non-Invasive Glucose Monitoring Market Size

The non-invasive glucose monitoring market was valued at USD 182.12 million in 2023. It is expected to grow at a CAGR of 8.3% during the forecast period of 2024-2032 and attain a market value of USD 373.26 million in 2032. The market value is impacted by the increasing use of such platforms and ongoing technological advancements in this field. There has been a significant increase in a number of patent applications associated with non-invasive glucose monitoring, driven by the increasing incidence of diabetes worldwide, leading to an increased demand for non-invasive glucose control solutions.

Patent Landscape Report Coverage

The Global Non-Invasive Glucose Monitoring Patent Landscape Report provides a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for non-invasive glucose monitoring includes a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within non-invasive glucose monitoring technologies.

Spectrometry is a powerful technique used to integrate non-invasive glucose monitoring with other platforms that can provide additional information. This can combine the strengths of different sequencing methods for more comprehensive genome analysis. Therefore, such technical innovations have a significant impact on the patent landscape.

Global Non-Invasive Glucose Monitoring Patent Outlook

• Increased innovations in optical, thermal, and spectroscopic technologies have improved the accuracy and reliability of non-invasive glucose monitoring devices. The application of new technologies in devices can lead to an increase in the number of patent applications in the coming years.

• Continuous inventions and innovations for improvements in non-invasive glucose monitoring technology are driven due to its advantages like reduced discomfort compared to traditional fingertip methods, which improves patient compliance.

• Non-invasive glucose monitoring is increasingly used with the growing elderly population base which is prone to diabetes. The utilization of these convenient monitoring solutions is driving the market demand and expanding the scope of this market.

What is Non-Invasive Glucose Monitoring?

Non-invasive glucose monitoring refers to methods and techniques that allow measuring blood sugar without piercing the skin (as with traditional fingertip methods). These methods typically use optical, thermal, electromagnetic, or other spectroscopic principles to estimate glucose levels through the skin or other body fluids. Non-invasive blood glucose monitoring aims to provide diabetics with convenient, painless, and continuous monitoring options that improve adherence to glucose monitoring programs and overall diabetes management.

Non-invasive glucose monitoring market continues to evolve, driven by the non-invasive devices integrated with wearable technology providing continuous monitoring and real-time information and improving management results. Also, support and funding policies by government and regulatory bodies for diabetes treatment and technologies is a driving factor to boost market value in the forecast period.

Non-Invasive Glucose Monitoring Industry Growth Drivers

Increasing Technological Advancements in Optical Sensing of Non-Invasive Glucose Monitoring is Expected to Augment the Market Growth

Advances in optical sensor technology for noninvasive glucose monitoring include innovations such as miniature sensors that use light to measure glucose levels through the interstitial fluid of the skin, improving patient outcomes and fueling market growth.

For instance, in 2023, Abbott announced that the U.S. FDA had cleared the application for its insulin delivery product “FreeStyle Libre 2” and “FreeStyle Libre 3”. This is an integrated continuous glucose monitoring (iCGM) sensor for integration into automated insulin delivery systems (AIDs). Abbott modified the sensors to allow integration with AID systems. Continuous development in devices is expected to boost the number of patent applications as companies involved in manufacturing wish to secure their intellectual property rights.

Integration of Machine Learning and Artificial Intelligence (AI) is Expected to Propel the Non-Invasive Glucose Monitoring Industry Growth

The integration of artificial intelligence and machine learning into non-invasive glucose monitoring systems improves data analysis capabilities, leading to enhanced accuracy and predictive power of glucose measurements. Companies are using artificial intelligence algorithms to interpret continuous glucose measurement data in real-time, providing users with personalized insights and alerts to better manage their diabetes by predicting trends and potential hypoglycemic or hyperglycemic events. The utilization of new technologies is likely to increase patent applications in the coming years.

Non-Invasive Glucose Monitoring Patent Segmentation

The report provides an in-depth analysis of the patents in this field by the following segmentation -

Breakup by Product Type

• Measuring Device

• Transmitter

• Software

Breakup by Sit Outlook

• Arm/Wrist

• Ear Lobe

• Forefinger

• Thumb

• Others

Breakup by Application

• Intensive Insulin Therapy

• Hypoglycemia

• Diabetic Foot Ulcer Tracking

• Others

Non-Invasive Glucose Monitoring Patent Segmentation Analysis

The breakup based on product type includes measuring devices, transmitters, and software. Spectrometer technology involves analysis by the absorption, emission or scattering of light to indirectly measure glucose levels in body tissues or fluids. This approach includes Raman spectroscopy, infrared spectroscopy, or other spectroscopic techniques to quantify glucose levels without invasive methods. It has become a promising option for continuous monitoring and better diabetes management.

The detailed technological data will be provided for all specified segments classified in this report.

Non-Invasive Glucose Monitoring Patent Jurisdiction Analysis

The United States is one of the leading jurisdictions for non-invasive glucose monitoring patents, having around 94,500 patents. The presence of a well-established healthcare infrastructure, a robust legal framework and prominent research institutions engaged in innovations contributes to the patent landscape significantly.

China is another significant jurisdiction. It has a substantial portion of the global geriatric population is witnessing rapid growth in patent filings. The expanding healthcare landscape in the region contributes to the evolving research capabilities, thereby influencing a surge in patent applications. Innovations like the development of other novel diagnostic methods is amongst the major growth factors.

Patent Profile of Key Companies

Among the players with non-invasive glucose monitoring patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the field.  Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:

Dexcom Inc.

This California-based company specializes in continuous glucose monitoring (CGM) systems. Although Dexcom's current offering is invasive (requiring a sensor to be implanted under the skin), it is actively developing non-invasive CGM technologies to improve ease of use and convenience in diabetes management. The goal is to provide accurate glucose monitoring solutions without repetitive fingertips.

Abbott Laboratories

A global healthcare company headquartered in Illinois is known for its innovative medical devices and diagnostics. Abbott revolutionized glucose monitoring with the FreeStyle Libre system, a CGM device that continuously measures glucose levels with a sensor on the skin, eliminating the need for conventional fingertips. Abbott continues to develop non-invasive glucose monitoring technologies to improve diabetes care and quality of life for patients worldwide.

Other companies include Genentech INC, Human Genome Sciences INC, and Novartis AG, among others.

Reasons to Purchase this Report

The Global Non-Invasive Glucose Monitoring Patent Report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by:

• Competitive Advantage: The landscape reveals the market leaders, potential partners and innovators also makes it understandable which companies have important patents in this field of Non-Invasive Glucose Monitoring.

• Innovation Insights: The patent analysis reveals new innovations and technologies in Non-Invasive Glucose Monitoring industry.

• Market Positioning: Companies with strong patent portfolios gain a competitive advantage because their intellectual property assets differentiate their products. Understanding their intellectual property strategy reveals the market position of new entrants and potential barriers to entry.

• Risk Assessment: In technology-intensive fields such as pumps for microfluidic devices, risks of IP infringement are common. Analysing patent landscapes helps companies assess risk, develop mitigation strategies, and inform licensing, partnering, and acquisition decisions.

• Legal and Regulatory Compliance: Understanding the patent landscape is critical to ensuring compliance with patent laws and regulations. It helps stakeholders navigate license agreements, avoid infringement lawsuits, and effectively use IP assets in a global marketplace.

Key Questions Answered in the Global Non-Invasive Glucose Monitoring Patent Landscape Report

• Who are the key players in the non-invasive glucose monitoring patent landscape?
• How is the patent portfolio distributed geographically?
• What are the emerging trends in non-invasive glucose monitoring patents?
• How has the patent landscape evolved over time?
• What are the strategic insights for market players and investors?
• What is the technological focus of patents in the non-invasive glucose monitoring industry?
• How do patent strategies impact the competitive landscape?
• What are the implications of patent filings in non-invasive glucose monitoring?
• What are the challenges and opportunities in the non-invasive glucose monitoring patent landscape?
• What are the regulatory and legal considerations?
• What technological innovations have recently emerged in non-invasive glucose monitoring?

Related Reports

Global Blood Glucose Meters Market

Global Glucose Monitoring Devices Market

Global Blood Glucose Test Strip Market

Global Glucose Market

North America Continuous Glucose Monitoring Market